Medtronic plc (MDT)
Medtronic Pays More Today. Abbott Raises Its Dividend Faster.
Both are Dividend Kings with decades of consecutive raises, but Medtronic and Abbott reward income investors in fundamentally different ways, and choosing the wrong one in retirement could cost you more than you expect.
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
Medtronic (MDT) closed at $93.01 in the latest trading session, marking a +1.17% move from the prior day.
Better Dividend Play for Retirees: MDT or ABT? One Delivers Significantly More Yield
Both Medtronic and Abbott have dropped in 2026, and those declines reshuffled the math on yield, valuation, and long-term growth in ways that push retirement investors toward a clear but maybe surprising choice.
Medtronic (MDT) Outperforms Broader Market: What You Need to Know
Medtronic (MDT) concluded the recent trading session at $87.97, signifying a +1.84% move from its prior day's close.
Medtronic's 49-Year Dividend Streak Faces a New Challenge: Is Growth Finally the Real Story?
Medtronic has raised its dividend for 49 straight years while the stock quietly lost a fifth of its value, but something in the operating room just changed the entire conversation about why investors should own it.
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Medtronic: Buy The 3% Yield And Strong Free Cash Flow Growth
Medtronic is initiated with a buy rating and a $106.33 price target, implying 17% upside and a 3% dividend yield. Q1 FY27 results exceeded expectations, with normalized revenue growth of 7% and notable strength in Cardiovascular and Neuroscience segments. Guidance was raised for revenue and EPS, but margin expansion is expected to materialize gradually as product mix shifts toward higher-margin recurring revenues.
Medtronic Sees AI, Ablation and Targeted M&A Fueling Growth
Medtronic NYSE: MDT Chief Financial Officer Thierry Piéton said the medical-device maker's focus on acute procedures, expanding innovation pipeline and increased use of targeted acquisitions are supporting its recent growth momentum.
Medtronic plc (MDT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Medtronic plc (MDT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott
Both Medtronic and Abbott have raised their dividends for nearly half a century, but retirement investors with limited capital can only choose one.
Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum
MDT lifts its 2027 outlook as broad-based growth accelerates, but margin pressure and competition could test momentum.
Medtronic Touts AI, Robotics and Ablation Growth at Wells Fargo Conference
Medtronic NYSE: MDT executives said the medical device maker is seeing accelerating growth across major franchises and emerging product categories, supported by innovation in artificial intelligence, robotics and new therapies.
